{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:09:21Z","timestamp":1789578561533,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2003,6,21]],"date-time":"2003-06-21T00:00:00Z","timestamp":1056153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1007\/s00277-003-0680-7","type":"journal-article","created":{"date-parts":[[2003,10,27]],"date-time":"2003-10-27T19:08:56Z","timestamp":1067281736000},"page":"463-468","source":"Crossref","is-referenced-by-count":15,"title":["Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation in myeloid diseases"],"prefix":"10.1007","volume":"82","author":[{"given":"U.","family":"Platzbecker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ehninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bornh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,6,21]]},"reference":[{"key":"680_CR1","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1056\/NEJM199804023381405","volume":"338","author":"Hansen","year":"1998","unstructured":"Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA, et al. (1998) Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 338:962\u2013968","journal-title":"N Engl J Med"},{"key":"680_CR2","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJM198106183042507","volume":"304","author":"Weiden","year":"1981","unstructured":"Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED (1981) Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 304:1529\u20131533","journal-title":"N Engl J Med"},{"key":"680_CR3","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, et al. (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 86:2041\u20132050","journal-title":"Blood"},{"key":"680_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1749-6632.1998.tb10488.x","volume":"850","author":"Sullivan","year":"1998","unstructured":"Sullivan KM, Anasetti C, Horowitz M, Rowlings PA, Petersdorf EW, Martin PJ, et al. (1998) Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry. Ann N Y Acad Sci 850:312\u2013324","journal-title":"Ann N Y Acad Sci"},{"key":"680_CR5","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0140-6736(98)03030-X","volume":"352","author":"Gratwohl","year":"1998","unstructured":"Gratwohl A, Hermans J, Goldman JM, Arcese W, Carreras E, Devergie A, et al. (1998) Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 352:1087\u20131092","journal-title":"Lancet"},{"key":"680_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1046\/j.1365-2141.2001.03074.x","volume":"115","author":"Bornhauser","year":"2001","unstructured":"Bornhauser M, Kiehl M, Siegert W, Schetelig J, Hertenstein B, Martin H, et al. (2001) Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis. Br J Haematol 115:119\u2013124","journal-title":"Br J Haematol"},{"key":"680_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1182\/blood.V97.3.631","volume":"97","author":"Giralt","year":"2001","unstructured":"Giralt S, Thall PF, Khouri I, Wang X, Braunschweig I, Ippolitti C, et al. (2001) Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood 97:631\u2013637","journal-title":"Blood"},{"key":"680_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1182\/blood-2002-02-0535","volume":"101","author":"Or","year":"2003","unstructured":"Or R, Shapira MY, Resnick I, Amar A, Ackerstein A, Samuel S, et al. (2003) Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. Blood 101:441\u2013445","journal-title":"Blood"},{"key":"680_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S1083-8791(01)80006-9","volume":"7","author":"Khoury","year":"2001","unstructured":"Khoury H, Adkins D, Brown R, Pence H, Vij R, Goodnough LT, et al. (2001) Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen. Biol Blood Marrow Transplant 7:352\u2013358","journal-title":"Biol Blood Marrow Transplant"},{"key":"680_CR10","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1046\/j.1365-2141.2000.02123.x","volume":"109","author":"Raiola","year":"2000","unstructured":"Raiola AM, Van Lint MT, Lamparelli T, Gualandi F, Mordini N, Berisso G, et al. (2000) Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60\u00a0years of age. Br J Haematol 109:716\u2013721","journal-title":"Br J Haematol"},{"key":"680_CR11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S0140-6736(02)07831-5","volume":"359","author":"Gratwohl","year":"2002","unstructured":"Gratwohl A, Baldomero H, Urbano-Ispizua A (2002) Transplantation in chronic myeloid leukaemia. Lancet 359:712\u2013713","journal-title":"Lancet"},{"key":"680_CR12","first-page":"2831","volume":"93","author":"Guardiola","year":"1999","unstructured":"Guardiola P, Anderson JE, Bandini G, Cervantes F, Runde V, Arcese W, et al. (1999) Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study. Blood 93:2831\u20132838","journal-title":"Blood"},{"key":"680_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1056\/NEJM200103083441016","volume":"344","author":"Deeg","year":"2001","unstructured":"Deeg HJ, Appelbaum FR (2001) Stem-cell transplantation for myelofibrosis. N Engl J Med 344:775\u2013776","journal-title":"N Engl J Med"},{"key":"680_CR14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1046\/j.1365-2141.2002.03884.x","volume":"119","author":"Hessling","year":"2002","unstructured":"Hessling J, Kroger N, Werner M, Zabelina T, Hansen A, Kordes U, et al. (2002) Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia. Br J Haematol 119:769\u2013772","journal-title":"Br J Haematol"},{"key":"680_CR15","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1182\/blood.V99.6.2255","volume":"99","author":"Devine","year":"2002","unstructured":"Devine SM, Hoffman R, Verma A, Shah R, Bradlow BA, Stock W, et al. (2002) Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia. Blood 99:2255\u20132258","journal-title":"Blood"},{"key":"680_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/ajcp\/56.1.24","volume":"56","author":"Bauermeister","year":"1971","unstructured":"Bauermeister DE (1971) Quantitation of bone marrow reticulin\u2014a normal range. Am J Clin Pathol 56:24\u201331","journal-title":"Am J Clin Pathol"},{"key":"680_CR17","doi-asserted-by":"crossref","unstructured":"Appelbaum FR, Rowe JM, Radich J, Dick JE (2001) Acute myeloid leukemia. Hematology (Am Soc Hematol Educ Program) 62\u201386","DOI":"10.1182\/asheducation-2001.1.62"},{"key":"680_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1046\/j.1468-0734.2002.00059.x","volume":"6","author":"Buchner","year":"2002","unstructured":"Buchner T, Hiddemann W, Berdel W, Wormann B, Schoch C, Loffler H, et al. (2002) Acute myeloid leukemia: treatment over 60. Rev Clin Exp Hematol 6:46\u201359","journal-title":"Rev Clin Exp Hematol"},{"key":"680_CR19","doi-asserted-by":"publisher","first-page":"743a","DOI":"10.1182\/blood.V98.3.743","volume":"98","author":"Sayer","year":"2001","unstructured":"Sayer HG, Kienast J, Ehninger G, Bornhauser M (2001) Dose-modified, fludarabine-based conditioning for allogeneic hematopoietic stem cell transplantation in 177 patients with acute myeloid leukemia not eligible for conventional transplantation. Blood 98:743a","journal-title":"Blood"},{"key":"680_CR20","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","volume":"97","author":"McSweeney","year":"2001","unstructured":"McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG, et al. (2001) Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 97:3390\u20133400","journal-title":"Blood"},{"key":"680_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1046\/j.1365-2141.2003.04057.x","volume":"120","author":"Feinstein","year":"2003","unstructured":"Feinstein LC, Sandmaier BM, Hegenbart U, McSweeney PA, Maloney DG, Gooley TA, et al. (2003) Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission. Br J Haematol 120:281\u2013288","journal-title":"Br J Haematol"},{"key":"680_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/sj.leu.2402423","volume":"16","author":"Schlenk","year":"2002","unstructured":"Schlenk RF, Hartmann F, Hensel M, Jung W, Weber-Nordt R, Gabler A, et al. (2002) Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia. Leukemia 16:581\u2013586","journal-title":"Leukemia"},{"key":"680_CR23","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1182\/blood.V99.3.1071","volume":"99","author":"Chakraverty","year":"2002","unstructured":"Chakraverty R, Peggs K, Chopra R, Milligan DW, Kottaridis PD, Verfuerth S, et al. (2002) Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. Blood 99:1071\u20131078","journal-title":"Blood"},{"key":"680_CR24","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1182\/blood.V98.8.2326","volume":"98","author":"de","year":"2001","unstructured":"de Witte T, Suciu S, Verhoef G, Labar B, Archimbaud E, Aul C, et al. (2001) Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS. Blood 98:2326\u20132331","journal-title":"Blood"},{"key":"680_CR25","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1182\/blood-2002-02-0527","volume":"100","author":"Deeg","year":"2002","unstructured":"Deeg HJ, Storer B, Slattery JT, Anasetti C, Doney KC, Hansen JA, et al. (2002) Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. Blood 100:1201\u20131207","journal-title":"Blood"},{"key":"680_CR26","unstructured":"Bornhaeuser M, Storer B, Slattery J, Appelbaum FR, Deeg HJ, Hansen J, et al. (2002) Conditioning with fludarabine and targeted busulfan before transplantation of allogeneic hematopoietic stem cells. Blood 100 [Suppl 1]:213a"},{"key":"680_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1046\/j.1365-2141.2002.03796.x","volume":"119","author":"Parker","year":"2002","unstructured":"Parker JE, Shafi T, Pagliuca A, Mijovic A, Devereux S, Potter M, et al. (2002) Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens. Br J Haematol 119:144\u2013154","journal-title":"Br J Haematol"},{"key":"680_CR28","first-page":"a827","volume":"25","author":"Kroger","year":"2002","unstructured":"Kroger N, Schwerdtfeger R, Bornhauser M, Ehninger G, Runde V, Beyer J, Kiehl M, Schetelig J, Siegert W, Sch\u00e4fer-Eckart K, Wandt H, Sayer HG, Kr\u00f6ger M, Zabelina T, Zander A (2002) Allogeneic stem cell transplantation after a dose-reduced conditioning in patients with MDS or sec. AML. Oncology 25:a827","journal-title":"Oncology"},{"key":"680_CR29","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1182\/blood-2002-02-0400","volume":"100","author":"Martino","year":"2002","unstructured":"Martino R, Caballero MD, Simon JA, Canals C, Solano C, Urbano-Ispizua A, et al. (2002) Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes. Blood 100:2243\u20132245","journal-title":"Blood"},{"key":"680_CR30","first-page":"894","volume":"87","author":"Ruiz-Arguelles","year":"2002","unstructured":"Ruiz-Arguelles GJ, Gomez-Almaguer D, Lopez-Martinez B, Cantu-Rodriguez OG, Jaime-Perez JC, Gonzalez-Llano O (2002) Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia. Haematologica 87:894-896","journal-title":"Haematologica"},{"key":"680_CR31","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1046\/j.1365-2141.2001.03174.x","volume":"115","author":"Mattsson","year":"2001","unstructured":"Mattsson J, Uzunel M, Brune M, Hentschke P, Barkholt L, Stierner U, et al. (2001) Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation. Br J Haematol 115:935-944","journal-title":"Br J Haematol"},{"key":"680_CR32","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1200\/JCO.2001.19.14.3340","volume":"19","author":"Michallet","year":"2001","unstructured":"Michallet M, Bilger K, Garban F, Attal M, Huyn A, Blaise D, et al. (2001) Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome. J Clin Oncol 19:3340-3349","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-003-0680-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-003-0680-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-003-0680-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-003-0680-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T09:42:37Z","timestamp":1585215757000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-003-0680-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,21]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["680"],"URL":"https:\/\/doi.org\/10.1007\/s00277-003-0680-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,21]]}}}